JUNCTURE WEALTH STRATEGIES, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1632866 SCOTTSDALE, AZ

Position in SUPN

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$297,850

New position

Shares Held

6,404

first reported quarter

Ownership

0.011%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

#208

of 333 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JUNCTURE WEALTH STRATEGIES, LLC holds $3,368,884 across 4 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	KNSA	Kiniksa Pharmaceuticals International, plc	17,824	$1,139,844
2	ETON	Eton Pharmaceuticals, Inc.	28,849	$1,044,333
3	NBIX	Neurocrine Biosciences Inc	5,262	$886,857
4	SUPN	Supernus Pharmaceuticals, Inc. This page	6,404	$297,850

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$297,850	6,404	—	Shares	Sole	2026-07-09
No filing history on record for this holder in this stock.